Email not displaying correctly?  View it in your browser.
 
Volume 8, Issue 3, September 2019
 


Director's message: Recognition for a job well done
After a rigorous review, NCI has renewed Mayo Clinic Cancer Center's elite designation and grant funding.
 
Features
 
Treatment of smoldering myeloma delays progression, study finds
Use of the drug lenalidomide instead of observation can delay symptom progression and organ damage.
Discrimination, gender bias toward health care staff common
Cancer doctors face racism and gender disparity from both patients and colleagues, studies find.
Breast cancer risk score buoys preventive medication use
A study that may change practice shows personal risk scores can encourage women to accept treatment.
Researchers test electronic nose to screen for Barrett's esophagus
A novel e-nose showed high accuracy, especially for patients taking high-dose proton pump inhibitors.
Less-invasive mastectomy safe option for more breast cancer patients
Even women with locally advanced cancer or at risk of complications could have nipple-sparing surgery.
3 factors may extend survival in advanced pancreatic cancer
A different approach to chemotherapy before surgery and radiation boosted average survival to 58.8 months.
Meet the Investigator: Donald W. Northfelt, M.D.
In this Cancer Center video, Dr. Northfelt discusses breast cancer and equity in clinical trials.
Mayo Clinic Cancer Center
13400 E. Shea Blvd.
Scottsdale, AZ 85259

4500 San Pablo Road
Jacksonville, FL 32224

200 First Street SW
Rochester, MN 55905